Role of the pressor action of angiotensin II in experimental hypertension.
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000138:chemical synthesis / Q000494:pharmacology / Q000502:physiology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D046508:Culture Techniques; D003900:Desoxycorticosterone; D004195:Disease Models, Animal; D006973:Hypertension / Q000209:etiology*; D006977:Hypertension, Renal / Q000209:etiology; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats; D012083:Renin / Q000097:blood; D014439:Tyramine / Q000037:antagonists & inhibitors; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors; D014667:Vasopressins / Q000037:antagonists & inhibitors
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D010656:Phenylephrine; D003900:Desoxycorticosterone; D012083:Renin; D009638:Norepinephrine; D014439:Tyramine